• SENSEX 80,543.99
    -166.26 (--0.21%)
  • BANKNIFTY 55,411.15
    50.90 (+0.09%)
  • N S D L
    943.85 943.85(%)
  • Adani Energy Sol
    780.00 588.25(%)
  • Sri Lotus
    197.00 197.00(%)
  • Bikaji Foods
    721.20 520.00(%)
  • Transrail Light
    808.20 808.20(%)
  • Godfrey Phillips
    10,875.25 10,875.25(%)
  • Waaree Energies
    3,246.60 3,740.75(%)
  • Newgen Software
    907.40 740.05(%)
  • Sarda Energy
    607.45 607.45(%)
  • Info Edg.(India)
    1,311.90 1,151.45(%)
  • Zinka Logistics
    570.95 570.95(%)
  • M & B Engineer.
    418.85 418.85(%)
  • Jayaswal Neco
    52.82 26.06(%)
  • Reliance Power
    47.58 76.49(%)
  • Schloss Bangal.
    414.00 382.50(%)
  • HDFC Bank
    1,988.15 2,036.30(%)
  • Aditya Infotech
    1,025.20 1,014.65(%)
  • Tata Motors
    650.45 542.55(%)
  • Mazagon Dock
    2,751.00 1,917.95(%)
  • Bharti Airtel
    1,921.85 1,422.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68575.0
  • ISIN : INE320X01016
1,161.70 -50 (-4.10%)
  • As on 06 Aug 2025 (EOD)

  • Today’s Low

    1,153.00

  • Today’s High

    1,220.90

  • Open

    1,215.40

  • Perv Close

    1,211.40

  • 52W Low

    861.55

  • 52W High

    1,749.65

Key Indicators

  • P/E(TTM)

    16.43

  • Mar.Cap (₹Cr.)

    351.22

  • Div & Yield %

    0.13

  • Book Value(₹)

    652.18

  • Debt-Equity Ratio

    -4.10

  • AGM Date

    06-Aug-2025

  • EPS

    70.69

  • P/E Ratio

    16.43

Financials Ratios

  • Debt-Equity Ratio

    0.58

  • Mar.Cap (₹Cr.)

    351.22

  • RONW (%)

    3.67

  • ROCE (%)

    7.24

Score Board

  • Equity (₹ in Cr.)

    3.02

  • BV (₹)

    652.20

  • Sales( ₹ in Cr.)

    333.37

  • NP (in Cr.)

    21.37

  • NP Var(%)

    81.0

  • Div%

    15.0

  • CPS (₹)

    104.60

  • EPS (₹)

    70.70

  • Traded Value (₹ in Lakhs)

    351.03

  • 52 Week High

    1,749.65

  • 52 Week Low

    861.55

  • Price BSE

    1161.0

  • Price NSE

    1,162.00

  • Market Capital( in Cr.)

    351.03

  • P/C Ratio

    11.10

  • P/E Ratio

    16.40

  • Price Vs.BV

    70.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 328.75 351.88 379.12 286.88 282.61 375.69
Excise Duty 28.75 36.63 33.49 26.63 25.68 31.53
Net Sales 300.00 315.25 345.63 260.25 256.93 344.16
Other Income 3.84 5.23 14.23 1.33 1.88 2.53
Stock Adjustments -0.98 -0.30 7.79 -1.90 -6.29 8.19
Total Income 302.86 320.18 367.65 259.68 252.52 354.88
EXPENDITURE :            
Raw Materials 161.19 189.95 216.16 137.76 155.75 238.47
Power and Fuel Cost 26.46 25.66 26.32 19.52 18.73 24.11
Employee Cost 37.94 34.72 32.51 27.11 23.27 20.63
Other Manufacturing Expenses 24.19 24.08 32.06 27.22 18.91 23.73
Selling and Administration Expenses 12.60 11.69 13.20 11.94 8.99 11.50
Miscellaneous Expenses 2.10 2.36 1.74 5.01 1.17 1.43
Employee Benefit Expenses 37.94 34.72 32.51 27.11 23.27 20.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 264.49 288.46 321.99 228.55 226.83 319.87
Operating Profit 38.38 31.71 45.65 31.14 25.68 34.99
Interest 9.01 5.16 4.68 4.57 5.10 5.46
Gross Profit 29.37 26.55 40.97 26.57 20.58 29.53
Depreciation 10.25 8.17 7.99 7.21 7.24 5.77
Profit Before Tax 19.12 18.38 32.98 19.36 13.34 23.76
Current Tax 4.05 3.15 7.56 5.03 3.30 6.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.99 2.01 0.04 1.16 0.89 0.83
Reported Net Profit 13.07 13.22 25.38 13.17 9.15 16.63
Extraordinary Items 1.27 1.87 9.47 0.01 0.06 -0.06
Adjusted Net Profit 11.80 11.35 15.91 13.16 9.09 16.69
Adjustment below Net Profit -0.41 0.05 -0.05 -0.09 -0.42 -0.06
P & L Balance brought forward 90.83 80.02 57.14 45.06 36.79 20.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.45 2.45 2.45 1.00 0.45 0.00
P & L Balance carried down 101.03 90.83 80.02 57.14 45.06 36.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 15.00 15.00 15.00 0.00 15.00
Dividend Per Share(Rs) 1.50 1.50 1.50 1.50 0.00 1.50
Earnings Per Share-Unit Curr 43.22 43.72 83.95 43.56 30.26 55.02
Earnings Per Share(Adj)-Unit Curr 43.22 43.72 83.95 43.56 30.26 55.02
Book Value 582.90 542.55 500.16 417.88 374.61 347.23
Book Value(Adj)-Unit Curr 582.90 542.55 500.16 417.88 374.61 347.23

Shareholding Pattern

  • Promoter Group

    71.41%

  • Public Share Holding

    28.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000 0.26 8,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,150,789 71.14 2,150,789 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,158,789 71.41 2,158,789 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,018 0.03 1,018 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,018 0.03 1,018 1
2] Non Institution
Bodies Corporate 83,667 2.77 83,615 58
Clearing Members 194 0.01 194 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,130 0.24 7,094 127
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 105,009 3.47 105,009 4
Individuals holding nominal share capital up to Rs. 1 lakh 667,390 22.08 659,492 7,200
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 61 0.00 0 1
Others 10 0.00 10 2
Sub Total 863,480 28.56 855,433 7,399
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,023,287 100.00 3,015,240 7,412

Company Background

SMS Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • SMS Lifesciences India Ltd
  • BSE Code : 68575.0
  • ISIN : INE320X01016

  • Incorporation Year

    2006

  • Registered Office

    Plot No 19-III Road No 71
    Opp Bharatiya Vidya Bhavan PSc, Hyderabad,
    Telangana-500096

  • Telephone

    91-040-6628-8888

  • FAX

    91-040-2355-1401

  • Chairman

  • Managing Director

    T V V S N Murthy

  • Company Secretary

    Trupti Ranjan Mohanty

  • Auditor

    Rambabu & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Lifesciences 1,161.10 303.84 328.75 16.43 10.68
Abbott India 32,614.05 6,684.73 6,409.15 49.00 44.95
Astrazeneca Phar 8,833.40 1,756.92 1,716.29 190.79 32.94
P & G Health Ltd 6,153.70 1,166.89 1,151.26 33.98 39.76
Glaxosmi. Pharma 2,711.85 3,866.05 3,723.49 48.77 58.72
Cipla 1,487.10 20,029.57 19,044.85 22.23 21.40
Amrutanjan Healt 664.30 437.58 421.23 37.79 20.84
Guj. Themis Bio. 354.80 174.19 169.82 86.75 44.82
Fermenta Biotec. 352.80 442.21 430.53 15.36 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 31.90 19.33 4.04 29.54 2.10